Cytek Biosciences (CTKB) Finished Goods (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Finished Goods data on file, last reported at $9.8 million in Q1 2026.

• For the quarter ending Q1 2026, Finished Goods fell 35.54% year-over-year to $9.8 million; the trailing twelve-month figure through Mar 2026 stood at $9.8 million (down 35.54% YoY), and the FY2025 full-year result was $11.5 million, down 22.78% from the prior year.
• Finished Goods for Q1 2026 stood at $9.8 million, down from $11.5 million in the prior quarter.
• Across five years, Finished Goods topped out at $22.8 million in Q1 2023 and bottomed at $9.8 million in Q1 2026.
• The 5-year median for Finished Goods is $15.3 million (2022), against an average of $15.9 million.
• The widest annual swing landed in 2022, when Finished Goods jumped 86.31%; it then slumped 35.54% in 2026.
• A 5-year view of Finished Goods shows it stood at $16.3 million in 2022, then slipped by 9.96% to $14.7 million in 2023, then gained by 0.88% to $14.8 million in 2024, then retreated by 22.78% to $11.5 million in 2025, then dropped by 14.36% to $9.8 million in 2026.
• The last three Finished Goods figures came in at $9.8 million (Q1 2026), $11.5 million (Q4 2025), and $20.3 million (Q3 2025), per Business Quant data.

Peer Comparison